15
Dec
2021
Watch
Preparation of the European Council meeting of 16-17 December 2021 - The EU's response to the global resurgence of Covid-19 and the new emerging Covid variants (debate)
Mr President, the response to the global resurgence of the pandemic and the summit with the African Union in early 2021 are closely linked issues at the next European Council. Indeed, the pandemic reappears largely because of the Omicron variant, which started in Africa, where the vaccination rate is 7%. And we know that the likelihood of new variants of the virus appearing where the vaccination rate is so low, is immense. Africa, and especially South Africa, urges the EU to temporarily lift patents on vaccines and related technologies. But the European Union says no. Is this our proposal for a partnership with the African Union? The argument that the lifting will not speed up the continent’s vaccination processes is false. Africa has at least six plants ready to produce messenger RNA vaccines in a matter of months and this would allow mass access to cost-effective vaccines and dedicate the continent’s resources to improving its logistics networks. But if this argument were true, it would be one more reason to suspend patents. Because in this case, the pharmaceutical industry has nothing to fear, because no one will be able to compete with it. The Omicron variant forced the suspension of the WTO meeting, where the European Union was going to violate the mandate of this Parliament. We still have time to rectify and do what the global interests of the planet, the interests of Africa and the interests of the EU itself demand of us.